Financial Statement

Fiscal Year Ends	:	December
( in million Rupiah except Par Value, Per Share Data and Ratios )
Statement Date	:	2024-03-31
Balance Sheet
Cash & Cash Equivalents	:	1,030
Curr. Assets	:	2,536
Fixed Assets	:	2,837
Total Assets	:	5,372
Curr. Liabilities	:	602
Long Term Debt	:	1,810
Minority Interest	:	0
Total Liabilities	:	2,412
Paid-Up Capital	:	86,512
Total Equity	:	2,961
Income Statement
Total Sales	:	472
Gross Profit	:	1
Operating Profit	:	-42
Net Income	:	-33
Cash Flow Statement
Cash From Operating Act	:	-387
Cash From Investing Act	:	-140
Cash From Financing Act	:	117
Per Share Data (in IDR)
EPS	:	-5.98
Book Value	:	542.52
Financial Ratios
Der	:	0.81
Roa	:	-0.28
Roe	:	-0.04
Npm	:	-0.07
Opm	:	-0.09
Growth Year to Year
Sales (%)	:	100.00%
Net Income (%)	:	100.00%
Total Assets (%) (%)	:	100.00%
Total Liabilities (%)	:	100.00%

1	RAK ICC Provides Strategic Solutions for Holding Companies and Regional Expansion

2	Illumina and PREMIA partner to expand clinical access to CGP in Asia

3	Rokid and Ant International Announce Integration of Smart Glasses Payment Capability

4	Salcomp's Debut on CES 2026

5	Call for Application for 2026 Tsinghua Amgen Scholars Program

RAK ICC Provides Strategic Solutions for Holding Companies and Regional Expansion